# Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

> **NCT07155707** · NA · NOT_YET_RECRUITING · sponsor: **Stanford University** · enrollment: 156 (estimated)

## Conditions studied

- Anxiety
- Mood Disorders

## Interventions

- **OTHER:** Teleo
- **OTHER:** Standard Videoconferencing

## Key facts

- **NCT ID:** NCT07155707
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2027-09-15
- **Final completion:** 2027-09-15
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2025-09-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07155707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07155707, "Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07155707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*